Show Stocks and Investing Publications • Fri, December 15, 2023
Ed Arce Maintained (TVTX) at Strong Buy with Increased Target to $20 on, Dec 15th, 2023
ntained-tvtx-at-strong-buy-with-increased-target-to-20-on-dec-15th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIEd Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $18 to $20 on, Dec 15th, 2023.
Ed has made no other calls on TVTX in the last 4 months.
There are 9 other peers that have a rating on TVTX. Out of the 9 peers that are also analyzing TVTX, 3 agree with Ed's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $10 on, Wednesday, October 25th, 2023
- Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
- Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023
These are the ratings of the 6 analyists that currently disagree with Ed
- Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
- Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
Like: 👍